The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Properties of Known Drugs. 2. Side Chains
Abstract
We continue our study of the common features present in drug molecules by looking in detail at drug side chains. Using shape description methods, we divide a database of commercially available drugs into a list of common drug side chains. On the basis of the atom pair shape descriptor (taking into account atom type, hybridization, and bond order), there are 1,246 different side chains among the 5,090 compounds analyzed. The average number of side chains per molecule is 4, and the average number of heavy atoms per side chain is 2. If we ignore the carbonyl side chain, then there are approximately 15,000 occurrences of side chains. Of these 15,000 approximately 11,000 are from the "top 20" group of side chains. This suggests that the diversity that side chains provide to drug molecules is quite low. We discuss ways that this work could be used to provide guidance for molecular design efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
Self-citationAtom pairs as molecular features in structure-activity studies: definition and applications
Carhart, R. E., Smith, D. H., & Venkataraghavan, R. (1985) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00046a002 · Cited by 1,066
Lewell, X. Q., Judd, D. B., Watson, S. P., & Hann, M. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci970429i · Cited by 691
Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484
Self-citationAmino acid side chain parameters for correlation studies in biology and pharmacology
FAUCHÈRE, J., CHARTON, M., KIER, L. B., VERLOOP, A., & PLISKA, V. (1988) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1988.tb01261.x · Cited by 384
Nilakantan, R., Bauman, N., Dixon, J. S., & Venkataraghavan, R. (1987) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00054a008 · Cited by 366
Designing Libraries with CNS Activity
Ajay, Bemis, G. W., & Murcko, M. A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990017w · Cited by 316
Self-citationPredicting ligand binding to proteins by affinity fingerprinting
Kauvar, L. M., Higgins, D. L., Villar, H. O., Sportsman, J. R., Engqvist-Goldstein, Å., Bukar, R., Bauer, K. E., Dilley, H., & Rocke, D. M. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90283-x · Cited by 208
Molecular Similarity Based on DOCK-Generated Fingerprints
Briem, H., & Kuntz, I. D. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950800y · Cited by 113
Murray, C. W., Clark, D. E., Auton, T. R., Firth, M. A., Li, J., Sykes, R. A., Waszkowycz, B., Westhead, D. R., & Young, S. C. (1997) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008094712424 · Cited by 73
Cited by
Simple Selection Criteria for Drug-like Chemical Matter
Muegge, I., Heald, S. L., & Brittelli, D. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015507e · Cited by 1,315
Feher, M., & Schmidt, J. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0200467 · Cited by 927
Reymond, J.-L. (2015) · Accounts of Chemical Research · doi:10.1021/ar500432k · Cited by 720
Expanding the medicinal chemistry synthetic toolbox
Boström, J., Brown, D. G., Young, R. J., & Keserü, G. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.116 · Cited by 665
Ligand efficiency indices as guideposts for drug discovery
Abad-Zapatero, C., & Metz, J. T. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03386-6 · Cited by 527
The application of in silico drug-likeness predictions in pharmaceutical research
Tian, S., Wang, J., Li, Y., Li, D., Xu, L., & Hou, T. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.009 · Cited by 498
Walters, W. P., & Murcko, M. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00003-0 · Cited by 439
Self-citationChemistry challenges in lead optimization: silicon isosteres in drug discovery
Showell, G. A., & Mills, J. S. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02726-0 · Cited by 427
Fragment-Based Lead Discovery Using X-ray Crystallography
Hartshorn, M. J., Murray, C. W., Cleasby, A., Frederickson, M., Tickle, I. J., & Jhoti, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0495778 · Cited by 422
What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
Walters, W. P., Green, J., Weiss, J. R., & Murcko, M. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200504p · Cited by 387
Self-citationFrequent substructure-based approaches for classifying chemical compounds
Deshpande, M., Kuramochi, M., Wale, N., & Karypis, G. (2005) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2005.127 · Cited by 371
Structural Diversity of Organic Chemistry. A Scaffold Analysis of the CAS Registry
Lipkus, A. H., Yuan, Q., Lucas, K. A., Funk, S. A., Bartelt, W. F., Schenck, R. J., & Trippe, A. J. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo8001276 · Cited by 302
Matched Molecular Pairs as a Medicinal Chemistry Tool: Miniperspective
Griffen, E., Leach, A. G., Robb, G. R., & Warner, D. J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200452d · Cited by 282
FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects
Lagorce, D., Sperandio, O., Galons, H., Miteva, M. A., & Villoutreix, B. O. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-396 · Cited by 263
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs
Proudfoot, J. R. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00244-5 · Cited by 252
Fragment Informatics and Computational Fragment‐Based Drug Design: An Overview and Update
Sheng, C., & Zhang, W. (2013) · Medicinal Research Reviews · doi:10.1002/med.21255 · Cited by 80
Metadata
- Authors
- Bemis, G. W., & Murcko, M. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-12-01
- Volume
- 42
- Issue
- 25
- Pages
- 5095-5099
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2003932717
- Cited by
- 271
- References
- 10
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.